About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Improved Breast MRI With SWIFT | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT01156987

Improved Breast MRI With SWIFT

Today's medical imaging methods have insufficient specificity for reliable differentiation between benign and malignant breast lesions in patients. Pathologic evaluation is currently the only way to o...

Lead sponsor: University of Minnesota•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

University of Minnesota

Collaborators

National Cancer Institute (NCI)

Patients will be asked to come to the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota. Researchers will interview the patient and describe procedures and risks. An intravenous (IV) line will be placed in an upper extremity for infusing magnetic resonance imaging (MRI) contrast dye. Baseline MRI scans will be done. These MRI measurements will be compared with clinical, radiological and pathological findings (the gold standard). Follow-up contact will occur within one year after the MRI to determine whether a pathology report is available.

Age

18 - 80 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Women with a clinically or mammographically identified suspicious breast mass that is likely to be biopsied or surgically removed.

Exclusion Criteria

•Pregnancy
•Ferromagnetic implants
•History of shotgun wounds and shrapnel
•Obesity (\>250 pounds)
•Cardiac pacemaker
•Incompatible implanted medical device
•Severe claustrophobia
•Major surgeries with potential of ferromagnetic implants
•Severe asthma and allergies
•i-STAT system, a handheld blood analyzer (I-STAT) creatinine test, estimated glomerular filtration rate (GFR) \<30
•Metallic object (greater than 2 cm in length) in the breast
•Metallic ink tatoo within 20 cm of the breast (approximately 8 inches)

Related studies

Exercise in Metastatic Breast Cancer: EMBody

NCT05468034 · Breast Cancer, Indolent Metastatic Breast Cancer

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

NCT04541381 · Gastrointestinal Cancer, Head and Neck Cancer, and more

Effects of Chemotherapy on Cognitive Function in Breast Cancer Patients & Non-Cancer Control Subjects With Optional Sub-Study Research Brain MRI

NCT03137095 · Cancer Related Cognitive Difficulties, Breast Cancer Female

A Pilot Trial of "Just ASK™" to Increase Discussions About Breast Cancer Clinical Trials

NCT07040891 · Breast Cancer

RECRUITINGPhase 3

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

NCT04852887 · Stage I Breast Cancer

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 9, 2017Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment31

Start dateAug 2009

Last updatedMar 9, 2017

Condition

Locations shown

Center for Magnetic Resonance Research

Minneapolis, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 9, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions